Z-1604-2024 Class II Ongoing

Recalled by Parker Laboratories, Inc. — Fairfield, NJ

FDA device recall Z-1604-2024 was initiated by Parker Laboratories, Inc. on Mar 22, 2024 and is designated Class II. Reason for recall: Product demonstrates low viscosity. The recall status is ongoing. Affected quantity: 217 cases (1,085 Inner Boxes; 10,850 Eaches).

Recall details

Product Type
Devices
Report Date
May 1, 2024
Initiation Date
Mar 22, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
217 cases (1,085 Inner Boxes; 10,850 Eaches)

Product description

Redux Electrolyte Creme, Product Ref. 66-04. Highly conductive electrolyte creme.

Reason for recall

Product demonstrates low viscosity.

Distribution pattern

Worldwide distribution - US Nationwide in the states of CA, CO, FL, GA, IL, MD, MI, MN, NC, NE, NY, OH, PA, SC, & TX. The countries of AU, CA, OM, & SA.

Code information

Product No. 66-04; UDI: 20855683006399 (Master), 10855683006392 (Inner Box), 00855683006395 (Each); Lot No. (Expiration Date): A1122010 (11/29/25) and A0523002 (5/12/26).

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1604-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1604-2024. Report a data issue: hello@regdatalab.com.